Read more at The Wall Street Journal.
Danone Backs Outlook as Sales, Volumes Beat Estimates
Date: |
Sort by
Filter
Date
Items per page
-
Pfizer beats earnings estimates, raises outlook on cost cuts and smaller-than-feared drop in Covid drug sales
The pharmaceutical giant's quarterly results also benefited from a smaller-than-feared drop in sales for its Covid antiviral pill Paxlovid.CNBC - Business - Covid -
Coca-Cola beats first-quarter earnings estimates, raises annual revenue outlook
Coca-Cola Co. reported better-than-expected first-quarter results before market open Tuesday, boosted by what the beverage giant described as “a dynamic backdrop.”MarketWatch - Business -
Yum Brands earnings miss estimates as Pizza Hut, KFC sales disappoint
KFC and Pizza Hut reported same-store sales declines, while Taco Bell's same-store sales rose just 1%.CNBC - Business -
Volkswagen Hit by Drop in Car Sales But Confirms Outlook
Volkswagen posted lower sales revenue and profit margins in the first quarter on fewer vehicle sales and higher costs, but backed its full-year outlook.The Wall Street Journal - Business -
Pfizer’s first-quarter results top estimates, while drugmaker boosts full-year profit outlook
Pfizer on Wednesday reported first-quarter results that beat analyst expectations, and raised its full-year profit guidance as cancer and heart-disease drugs helped offset plummeting COVID product sales.MarketWatch - Business -
GSK raises profit outlook on strong vaccine and HIV drug sales
Quarterly results beat expectations and signal strong start for pharma groupFinancial Times - Business -
Mercedes-Benz Posts Profit Beat Despite Lower Car Sales
Mercedes-Benz reported lower profit and revenue for the first quarter fell on fewer cars sales and supply-chain bottlenecks but confirmed its guidance for the year.The Wall Street Journal - Business -
Next Backs Guidance as Sales Rise Tops Hopes
Next reiterated its guidance for fiscal 2025, forecast an adjusted profit of £960 million, after reporting an above-forecast rise in full-price sales for the first quarter.The Wall Street Journal - World -
Next Backs Guidance as Sales Rise Tops Hopes
Next reiterated its guidance for fiscal 2025, forecast an adjusted profit of £960 million, after reporting an above-forecast rise in full-price sales for the first quarter.The Wall Street Journal - Business -
Kevlar, Tyvek parent DuPont’s stock surges after big profit beat, raised outlook
CEO Ed Breen says results confirm that electronics business is now past the bottom, and “on road to recovery.”MarketWatch - Business
More from The Wall Street Journal
-
Exxon to Close Megadeal; Pioneer Ex-CEO to Be Barred from Exxon Board in Deal With FTC
Antitrust enforcers are set to allege former Pioneer CEO Scott Sheffield discussed coordinating oil-production levels with other producers and OPEC.The Wall Street Journal - Business -
Narcan-Maker Emergent BioSolutions to Cut 300 Jobs, Close Facilities
Emergent BioSolutions is closing several manufacturing facilities and cutting hundreds of jobs as part of a restructuring as the company narrows its focus on products, including Narcan nasal spray.The Wall Street Journal - Business -
CVS Made a Big Bet on Medicare. It's Looking Risky.
The company’s Medicare business, hit by higher medical costs, pushed down CVS’s first-quarter earnings.The Wall Street Journal - Business -
Restaurant Winners Have a Common Trait: Keeping a Lid on Prices
Restaurant chains outperforming their competitors seem to have one thing in common: keeping prices down.The Wall Street Journal - Business -
Puig Policy to Exclude Next Generation Can Help Ease Succession Concerns
As succession drama grips corners of the luxury world, Puig’s decision to ban its next generation from working there is getting a favorable view ahead of its initial public offering.The Wall Street Journal - Business